About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

Massachusetts General Hospital announced that Tim Andrews recovered well enough from the transplant to leave the hospital a ...

Inc., a pharmaceutical company currently trading at $0.60 with a market capitalization of $71 million, has been notified by the Nasdaq Stock Market of non-compliance with the minimum bid price ...

Surgeons at Massachusetts General Hospital have successfully performed the fourth pig kidney transplant in the U.S.

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

FDA approves the first clinical trials for pig kidney transplants in humans, testing genetically modified pig organs.

A 66-year-old New Hampshire man received the kidney as part of a small pilot study at Mass General Brigham. United Therapeutics, another developer of gene-edited pig organs, just won FDA approval for ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

The second person ever has received a transplant with a genetically modified pig kidney.